29 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
have significantly greater financial, manufacturing, marketing, drug development, technical and human resources, and commercial expertise than Apexigen … , manufacturing, commercial, drug development and technical expertise and human resources than Apexigen. Large pharmaceutical and biotechnology companies
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:03pm
financial, manufacturing, marketing, drug development, technical and human resources, and commercial expertise than we do. Large pharmaceutical … of salaries, benefits, and stock-based compensation expense for personnel in executive, operations, legal, human resources, finance and administrative
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:02pm
, operations, legal, human resources, finance and administrative functions, professional fees for legal, patent, consulting, accounting and audit services … , manufacturing, commercial, drug development and technical expertise and human resources than we do. Large pharmaceutical and biotechnology companies
POS AM
3uqk1k 4hi9v4pp1
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
g1fwoxntflajdkjq
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
424B3
mygai 2obm5sc2g8em
9 Sep 22
Prospectus supplement
4:40pm
424B3
y9jve5g 9q1zvbmq
9 Sep 22
Prospectus supplement
4:38pm
8-K/A
EX-99.2
h4xfitemc2v1u
18 Aug 22
Index to Unaudited Condensed Financial Statements
4:48pm
8-K
EX-10.6
ktg fv8twe7bt3p
4 Aug 22
Entry into a Material Definitive Agreement
4:32pm
8-K
EX-10.5
k13nmica2 1dgp2lgsjf
4 Aug 22
Entry into a Material Definitive Agreement
4:32pm
424B3
l9czb rui
6 Jul 22
Prospectus supplement
4:18pm